Detail akcie Positron online

Business Summary: Positron Corporation (Positron) is a nuclear medicine healthcare company. The Company specializes in the business of cardiac Positron Emission Tomography (PET). The Company operates through two segments: medical equipment and radiopharmaceuticals. Its segments operate in the nuclear medicine industry. Positron's products and services enable healthcare providers to diagnose disease. Positron focuses on providing an end-to-end solution for PET myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals and radioisotopes. The Company offers Attrius, which is a PET system. Attrius is a PET scanner optimized for cardiology. Attrius is optimized for myocardial perfusion imaging. The Company is engaged in manufacturing and production of radioisotopes. Positron produces active pharmaceutical ingredient (API) grade Strontium-82 (Sr-82). The Company offers PosiRx, which is an automated dose preparation system.
Financial Summary: BRIEF: For the nine months ended 30 September 2015, Positron Corp revenues decreased 19% to $978K. Net loss decreased 53% to $1.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Interest Exp-Net of Capitalized Interest decrease of 77% to $419K (expense), General and administrative decrease of 35% to $1.1M (expense).